Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-072548
Filing Date
2025-05-15
Accepted
2025-05-15 16:01:36
Documents
64
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-20250331.htm   iXBRL 10-Q 1553035
2 EX-31.1 scyx-ex31_1.htm EX-31.1 18237
3 EX-31.2 scyx-ex31_2.htm EX-31.2 18775
4 EX-32.1 scyx-ex32_1.htm EX-32.1 12357
  Complete submission text file 0000950170-25-072548.txt   8033804

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20250331.xsd EX-101.SCH 1076118
67 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20250331_htm.xml XML 1708880
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 25952400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)